Details about Margaret K. Kyle

Access statistics for papers by Margaret K. Kyle.

Last updated 2013-01-12. Update your information in the RePEc Author Service.

Short-id: pky20

Working Papers

2011

1. Inefficiencies in technology transfer: theory and empirics
   CEPR Discussion Papers, C.E.P.R. Discussion Papers View citations (1)
2. Inefficiencies in the sale of ideas: theory and empirics
   Working Papers, HAL
3. Investments in Pharmaceuticals Before and After TRIPS
   CEPR Discussion Papers, C.E.P.R. Discussion Papers
   Also in NBER Working Papers, National Bureau of Economic Research, Inc (2009)
   See also Journal Article in The Review of Economics and Statistics (2012)

2010

4. Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets
   Open Access publications from University of Toulouse 1 Capitole, University of Toulouse 1 Capitole

2008

5. Does Re-importation Reduce Price Differences for Prescription Drugs? Lessons from the European Union
   Open Access publications from University of Toulouse 1 Capitole, University of Toulouse 1 Capitole View citations (2)

2007

6. Generic Competition and Market Exclusivity Periods in Pharmaceuticals
   Open Access publications from University of Toulouse 1 Capitole, University of Toulouse 1 Capitole View citations (6)
   See also Journal Article in Managerial and Decision Economics (2007)
7. Pharmaceutical Price Controls and Entry Strategies
   Open Access publications from University of Toulouse 1 Capitole, University of Toulouse 1 Capitole View citations (19)
   See also Journal Article in The Review of Economics and Statistics (2007)
8. Strategic Responses to Parallel Trade
   NBER Working Papers, National Bureau of Economic Research, Inc View citations (10)
   See also Journal Article in The B.E. Journal of Economic Analysis & Policy (2011)
9. Would Greater Transparency and Uniformity Of Health Care Prices Benefit Poor Patients?
   Open Access publications from University of Toulouse 1 Capitole, University of Toulouse 1 Capitole

2006

10. Public & Private Spillovers, Location and the Productivity of Pharmaceutical Research
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (3)
    See also Journal Article in Annales d'Economie et de Statistique (2005)
11. The Role of Firm Characteristics in Pharmaceutical Product Launches
    Open Access publications from University of Toulouse 1 Capitole, University of Toulouse 1 Capitole View citations (7)
    See also Journal Article in RAND Journal of Economics (2006)

2000

12. Did U.S. Bank Supervisors Get Tougher During the Credit Crunch? Did They Get Easier During the Banking Boom? Did It Matter to Bank Lending?
    NBER Working Papers, National Bureau of Economic Research, Inc View citations (7)
    Also in Finance and Economics Discussion Series, Board of Governors of the Federal Reserve System (U.S.) (2000) View citations (1)
    See also Chapter (2001)

Journal Articles

2012

1. Investments in Pharmaceuticals Before and After TRIPS
   The Review of Economics and Statistics, 2012, 94, (4), 1157-1172
   See also Working Paper (2011)

2011

2. Strategic Responses to Parallel Trade
   The B.E. Journal of Economic Analysis & Policy, 2011, 11, (2), 2 View citations (1)
   See also Working Paper (2007)

2007

3. Generic competition and market exclusivity periods in pharmaceuticals
   Managerial and Decision Economics, 2007, 28, (4-5), 491-502 View citations (4)
   See also Working Paper (2007)
4. Pharmaceutical Price Controls and Entry Strategies
   The Review of Economics and Statistics, 2007, 89, (1), 88-99 View citations (26)
   See also Working Paper (2007)

2006

5. The Role of Firm Characteristics in Pharmaceutical Product Launches
   RAND Journal of Economics, 2006, 37, (3), 602-618 View citations (9)
   Also in RAND Journal of Economics, 2006, 37, (3), 602-618 (2006) View citations (6)
   See also Working Paper (2006)

2005

6. Public & Private Spillovers: Location and the Productivity of Pharmaceutical Research
   Annales d'Economie et de Statistique, 2005, (79-80), 165-188
   See also Working Paper (2006)

2004

7. Does locale affect R&D productivity? the case of pharmaceuticals
   FRBSF Economic Letter, 2004, (Nov 12)

Chapters

2010

1. Public and Private Spillovers: Location and the Productivity of Pharmaceutical Research
   A chapter in Contributions in Memory of Zvi Griliches, 2010, pp 165-188 View citations (7)

2003

2. The Long Shadow of Patent Expiration. Generic Entry and Rx-to-OTC Switches
   A chapter in Scanner Data and Price Indexes, 2003, pp 229-274 View citations (8)

2001

3. Did U.S. Bank Supervisors Get Tougher during the Credit Crunch? Did They Get Easier during the Banking Boom? Did It Matter to Bank Lending?
   A chapter in Prudential Supervision: What Works and What Doesn't, 2001, pp 301-356 View citations (9)
   See also Working Paper (2000)

Software Items

1997

1. MATLAB/C code for GIG and BNLG common value auction specifications
   Matlab codes